Introduction
============

Cardiovascular disease (CVD) is the leading cause of death in women ([@B1]) and the third leading cause of death among women of reproductive age (defined as 18-44 y unless otherwise specified) ([@B2]). The prevalence of hypertension and dyslipidemia, 2 major CVD risk factors, is relatively high among women of reproductive age. During 2005 through 2008, 8% of women aged 20 to 44 years had hypertension or were taking hypertension medication ([@B2]), and 11% had dyslipidemia ([@B2]). Although hypertension prevalence rates have remained stable during the last 10 years, approximately 40% of reproductive-aged adults (both men and women) with hypertension are unaware they have the condition ([@B3]).

Overall, women of reproductive age are not generally considered to be at high risk for CVD, but identification of hypertension and dyslipidemia has reproductive health significance. For women of reproductive age with hypertension, combined hormonal contraceptive methods are generally not recommended because they may increase CVD risk. Additionally, hypertension during pregnancy is associated with adverse outcomes such as preeclampsia, placenta abruption, preterm delivery, low birth weight, and infant death ([@B4]-[@B7]). Dyslipidemia is associated with polycystic ovary syndrome ([@B8]), the most common endocrine disorder among women of reproductive age and a leading cause of infertility ([@B9]). Dyslipidemia during pregnancy may also have adverse effects on both the fetus and mother ([@B10],[@B11]).

Because women of reproductive age are at risk of becoming pregnant and drug therapy may pose risks to the fetus, lifestyle modifications are often the first line of treatment for hypertension or dyslipidemia. The effectiveness of lifestyle interventions such as exercise and diet on cardiovascular outcomes is well established for men and older women ([@B12]-[@B18]), but their effects on women of reproductive age are largely unknown. Reviewing hypertension and dyslipidemia screening recommendations for consistency between guidelines and understanding screening prevalence for women of reproductive age may clarify intervention referral opportunities. To our knowledge, no published reports have compared screening guidelines as they pertain to this population.

The primary objective of this systematic review was to evaluate the evidence from randomized controlled trials (RCTs) that have investigated the effects of lifestyle interventions on hypertension, dyslipidemia, or CVD illness and death in this population. Secondary objectives were to review hypertension and dyslipidemia recommendations for consistency and to report the prevalence of screening among women of reproductive age.

Methods
=======

Data sources
------------

Using electronic bibliographic databases (PubMed/MEDLINE, Cochrane Database of Systematic Reviews, and US National Guideline Clearinghouse), we conducted electronic searches on lifestyle interventions, national hypertension and dyslipidemia screening guidelines, and screening prevalence for women of reproductive age from January 1, 1990, through November 18, 2010. We also searched for relevant guidelines published by the American College of Obstetricians and Gynecologists. To conduct the search, we used a combination of free text terms and concepts derived from the National Library of Medicine\'s medical subject headings ([Table 1](#T1){ref-type="table"}). We applied additional filter options (English language and human studies) and related search features in iterative fashion to identify all relevant literature. In addition, we reviewed reference lists from retrieved articles and searched the grey literature, which consists of reports, studies, articles, and monographs produced by federal and local government agencies, private organizations, and educational institutions.

Study selection
---------------

**Lifestyle interventions**

Two researchers (S.T., M.T.) searched the literature independently and selected studies on the basis of a priori inclusion criteria. We used researcher agreement to reconcile questions that arose about eligibility. We found no systematic reviews or meta-analyses of the effect of lifestyle interventions on CVD illness or death that focused on women of reproductive age or that parsed data to allow such analysis. Therefore, we used the following a priori inclusion criteria to identify individual studies: 1) RCTs or randomized crossover study designs; 2) enrolled 10 or more women of reproductive age or whose sample included subgroup analyses for women of reproductive age, or both; 3) full-length article; 4) outcomes of blood pressure, lipids, or CVD illness or death, or all; 5) diet or exercise intervention or both; and 6) published in the English language. Twenty-one of 555 studies (3.8%) met all a priori selection criteria and addressed 1 or more relevant outcomes ([Figure](#F1){ref-type="fig"}).

![Selection of individual studies examining the effects of lifestyle interventions on hypertension, dyslipidemia, and cardiovascular disease illness and death among adult women of reproductive age. Abbreviations: RCT, randomized controlled trial; WRA, women of reproductive age.](PCD86A123s01){#F1}

**Screening recommendations**

Of particular interest to this review was an examination of guidelines likely to be in current use. As such, we focused on national-level US-based guidelines. We examined evidence-based guidelines produced under the auspices of medical specialty associations, relevant professional societies, and federal government agencies that had been reviewed, revised, or developed within the last 5 years (2005-2010), with the exception of 2 older seminal guidelines (the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure \[JNC 7\] and the Adult Treatment Panel III cholesterol guidelines, both sponsored by the National Heart, Lung, and Blood Institute \[NHLBI\]), which continue to be referenced by other current guidelines. To be included in our assessment, a guideline had to meet the evidence-based criteria required for acceptance in the National Guideline Clearinghouse ([www.guideline.gov/about/inclusion-criteria.aspx](www.guideline.gov/about/inclusion-criteria.aspx)).

**Screening prevalence**

To describe current hypertension and dyslipidemia screening practices in the target population, we focused our searches on studies emanating from large population-based surveys in the United States, including the Behavioral Risk Factors Surveillance System (BRFSS), the Medical Expenditure Panel Survey (MEPS), the National Ambulatory Medical Care Survey (NAMCS), the National Health Interview Survey (NHIS), the National Health and Nutrition Examination Survey (NHANES), and the National Survey of Family Growth (NSFG).

**Data extraction**

We extracted data from included studies into comprehensive evidence tables to facilitate assessment of the quality of the individual studies. For the purposes of this report, we present details on the study setting and population, intervention, results (significant changes in outcomes in intervention groups relative to controls), and study quality from lifestyle intervention articles. We present included studies in descending chronological order, identified by first author and year (Tables [2](#T2){ref-type="table"}, [3](#T3){ref-type="table"}, and [4](#T4){ref-type="table"}). We used a validated instrument designed to evaluate the internal validity of controlled studies to assess the quality of each of the studies. ECRI Institute (Plymouth Meeting, Pennsylvania) developed the instrument, which is available on request from the authors ([@B19]). We made no attempt to analyze or synthesize the findings quantitatively because of the large variation in the interventions assessed. Instead, we summarize the data qualitatively.

We extracted the following elements from hypertension and dyslipidemia guidelines: year, target population, recommended screening interval for all healthy and at-risk women of reproductive age, risk factors, and diagnostic criteria ([Table 5](#T5){ref-type="table"}). Lastly, we describe screening prevalence estimates for hypertension and dyslipidemia among women of reproductive age obtained from 2 studies that used population-based surveys.

Results
=======

Lifestyle interventions
-----------------------

Of 555 retrieved references, we identified 21 studies that met our inclusion criteria, including diet interventions (n = 3), exercise interventions (n = 13), and combined diet and exercise interventions (n = 5). Eighteen studies examined the effect of an intervention on lipid levels, 9 examined blood pressure measures, and none focused on CVD illness or death. Study follow-up ranged from 6 weeks to 2 years. After reading the abstracts or the entire text, we excluded approximately 96% of the studies (534 of 555) largely because data precluded separate analyses of women of reproductive age (78%) ([Figure](#F1){ref-type="fig"}). Additionally, 14% were excluded because our targeted outcomes were not addressed, and 8% were not RCTs or crossover study designs. We summarized findings from the trials that investigated the effect of diet, exercise, and combined diet and exercise interventions on systolic blood pressure (SBP), diastolic blood pressure (DBP), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and triglycerides (TG).

**Diet alone**

We summarized data from 3 low- to moderate-quality, randomized crossover studies ([@B20]-[@B22]) involving 86 women of reproductive age that met our inclusion criteria ([Table 2](#T2){ref-type="table"}). All examined lipid levels and 1 also examined blood pressure measures ([@B21]). Study settings included Australia and the United States, and all studies compared low-fat to higher-fat diets and reported reduced mean values in TC (10.8-30.2 mg/dL), LDL-C (8.7-26.3 mg/dL), and HDL-C (3.4-10.1 mg/dL) for participants who followed low-fat diets. The study that examined blood pressure reported significant mean reductions in DBP (4.4 mm Hg) and arterial pressure (3.8 mm Hg) but not SBP for participants following a low-fat diet.

**Exercise alone**

Thirteen RCTs (12 moderate quality, 1 high quality) involved 482 women of reproductive age ([Table 3](#T3){ref-type="table"}). Exercise modes included resistance and endurance training, walking, running, and aerobics; study duration ranged from 6 to 40 weeks with varying intensities. Ten RCTs ([@B23]-[@B32]) examined lipids and 5 examined blood pressure ([@B23],[@B31],[@B33]-[@B35]). All lipid RCTs evaluated TC, LDL-C, HDL-C, and TG except 1, which did not examine LDL-C ([@B32]). Study settings were Brazil, Ireland, Nigeria, Turkey, and the United States.

Findings were mixed for the impact of exercise on lipid levels among women of reproductive age. In 3 of 10 trials, significant reductions in mean TC levels were found among those who received resistance training (12.8-16.3) or aerobics (28.2-39.8), compared with controls ([@B25],[@B27],[@B29]). Among 2 recent studies that examined TC, resistance training significantly reduced mean TC (12.8 mg/dL) compared with controls, but stair climbing did not ([@B24],[@B29]). The other 7 studies that examined TC demonstrated no significant impact from exercise ([@B23],[@B24],[@B26],[@B28],[@B30]-[@B32]). Two of 9 trials examining LDL-C showed that stair climbing ([@B24]) and resistance training ([@B29]) led to significant mean improvements among women of reproductive age (6.6 and 13.9 mg/dL, respectively). However, 7 studies demonstrated no significant changes in LDL-C resulting from exercise ([@B23],[@B25]-[@B28],[@B30],[@B31]). Only 1 study in 10 examining HDL-C demonstrated that exercise had a positive effect; it showed a mean increase of 6.5 mg/dL for step aerobics ([@B25]). Another study suggested undesirable effects of exercise on HDL-C ([@B30]), and 8 trials demonstrated no significant alterations to HDL-C ([@B23],[@B24],[@B26]-[@B29],[@B31]-[@B32]). None of the RCTs demonstrated significant changes in TG in response to exercise.

Only 1 of the 5 trials examining blood pressure found an impact of exercise ([@B35]). That RCT showed continuous and interval aerobic training reduced SBP 10.8 to 12.4 mm Hg and DBP 2.5 to 2.6 mm Hg. None of the other RCTs demonstrated significant changes in blood pressure due to exercise.

**Combined diet and exercise interventions**

Five RCTs (1 low quality, 3 moderate quality, 1 high quality) representing 443 women of reproductive age ([Table 4](#T4){ref-type="table"}) examined TC, HDL-C, and TG; 3 examined LDL-C ([@B36]-[@B38]); and 3 examined blood pressure ([@B38]-[@B40]). Interventions varied in duration, ranging from 14 weeks to 2 years. Study settings were Canada, Finland, Italy, and the United States. The high-quality RCT was the most recent study, had the largest sample (120 obese women of reproductive age), the longest intervention period, and provided monthly sessions with a nutritionist and exercise trainer for the first year and bimonthly sessions in the second year ([@B39]). Interventions tested in the other RCTs included weight-reduction diets coupled with walking and group education ([@B40]) or with aerobics or resistance training ([@B36]); and aerobic exercise with low-fat diet and group education ([@B38]) or with fish diet ([@B37]).

Only 1 US RCT ([@B38]) found significant protective differences among the intervention groups relative to controls for TC and LDL-C reporting mean decreases in TC for the diet plus exercise group (10.8 mg/dL) and diet only (15.1 mg/dL), and in LDL-C for both intervention groups (11.2 and 10.9 mg/dL, respectively). One RCT focusing on obese women reported a 8.0 mg/dL mean increase in HDL-C among the intervention group ([@B39]). Four RCTs showed no effect of diet and exercise on HDL-C ([@B36]-[@B38],[@B40]).

Three RCTs ([@B37]-[@B39]) found significant mean TG reductions (1.8-19.0 mg/dL) among intervention groups. The other 2 studies demonstrated no significant changes in TG ([@B36],[@B40]).

Two studies ([@B38],[@B39]) reported significant mean decreases in SBP (3.0-4.1 mm Hg) and DBP (2.0-3.0 mm Hg) among the intervention groups relative to controls. The other study that examined blood pressure demonstrated no significant changes as a result of diet and exercise ([@B40]).

Current recommendations for hypertension and dyslipidemia screening and lifestyle modifications
-----------------------------------------------------------------------------------------------

Seven national US guidelines containing recommendations for hypertension and dyslipidemia screening were identified ([Table 5](#T5){ref-type="table"}). The guidelines for hypertension screening intervals and diagnostic criteria among women of reproductive age were generally consistent. Less agreement was observed between guidelines in the criteria for diagnosing dyslipidemia and cholesterol screening recommendations for women of reproductive age.

Five of the guidelines explicitly or by deferral to the NHLBI JNC7 guidelines ([@B41]) recommend hypertension screening every 2 years for adult women with optimal blood pressure (\<120/80 mm Hg) and more frequently for those who have prehypertension or have other risk factors ([@B41]-[@B46]) ([Table 5](#T5){ref-type="table"}). Guidelines differ with regard to age at which hypertension screening should begin. The guidelines also vary in definitions of at-risk populations, but the following risk factors are consistent across guidelines: smoking, diabetes, obesity, physical inactivity, older age (\>65 years for women), and having a personal or family history of premature CVD, hypertension, or dyslipidemia (\<65 y for women and \<55 y for men). The American Heart Association (AHA) also addresses pregnancy conditions and other gender-related comorbidities that identify women at risk ([@B43]). All organizations recommend that a series of standardized blood pressure measurements be taken over multiple visits before a diagnosis of hypertension is made, but there are nuanced differences between guidelines.

Lifestyle modifications, in particular exercise and weight reduction, were universally recommended by all guidelines as an integral part of CVD prevention and as first-line treatment for milder forms of hypertension. In addition, most recommend smoking cessation, maintaining a healthy diet rich in fruits and vegetables, and reduction of alcohol and sodium intake.

National cholesterol guidelines concur that women at increased risk of coronary heart disease (CHD) should be screened for dyslipidemia. However, only AHA ([@B43]) and NHLBI Adult Treatment Program III ([@B48]) recommend screening women of reproductive age (≥20 y) who are not at increased risk. Increased risk is generally defined by the presence of 1 or more of the following: diabetes, previous personal history of CHD or noncoronary atherosclerosis, a family history of premature CVD, current tobacco use, hypertension, or obesity. Screening frequency recommendations are similar, generally every 5 years, with shorter intervals for women whose lipid levels are close to warranting therapy, and longer intervals for those not at increased risk if they have repeatedly had normal lipid levels. Most organizations recommend that a full lipid profile be obtained and that lipid screening be performed after a fast of 9 to 12 hours. However, there is some disagreement between guidelines about the need for fasting blood levels and the value of including triglycerides as a part of the initial tests ([@B49]). Furthermore, consensus about diagnostic criteria for dyslipidemia is lacking ([Table 5](#T5){ref-type="table"}). Most guidelines recommend the same CVD risk reduction lifestyle modifications for cholesterol management as mentioned previously for hypertension, except sodium reduction. Additionally, they emphasize high-fiber, low-fat diets.

**Screening prevalence**

We identified only 2 hypertension and dyslipidemia screening prevalence studies that used population-based data and included women of reproductive age. The sole report that examined hypertension screening rates among women of reproductive age (defined as 14-44 y) was based on 1988 NSFG data ([@B50]) and estimated annual hypertension screening within the preceding year to be 82.3%. Predictors of hypertension screening among women of reproductive age in that report included having had a family planning visit in the previous 12 months, current or recent pregnancy, history of hypertension, older age, black race, and higher education or income ([@B50]). Only 1 study reported cholesterol screening rates among women of reproductive age, and it used 1999-2006 National Health and Nutrition Examination Survey (NHANES) data ([@B51]). That study reported 49% of women aged 20 to 45 years with no CHD risk factors received cholesterol screening within the preceding 5 years. Screening rates were 52% among women with 1 risk factor and 69% among those with CHD or CHD equivalent risk.

Discussion
==========

Limited conclusions can be drawn about lifestyle interventions in women of reproductive age because of the small number of included RCTs, the heterogeneity of interventions examined, and the lack of consistent findings across studies. Lifestyle interventions improved dyslipidemia in 10 of 18 studies and hypertension in 4 of 9 studies. Stronger benefit was seen on levels of TC and LDL-C than on HDL-C or TG. Improvements in systolic blood pressure were seen in 3 of 9 studies that examined blood pressure changes. Diastolic blood pressure improved in 4 of 9 studies. Follow-up tended to be short-term (1-2 y), and most samples comprised healthy women of reproductive age.

Our assessment of the effectiveness of lifestyle intervention is consistent with reviews conducted on low-risk populations. A systematic review of lifestyle interventions among healthy adult men and women also concluded that lifestyle interventions offered marginal short-term benefit on blood pressure and, to a lesser degree, lipids ([@B52]). Two meta-analyses examined the effect of aerobic exercise on blood pressure and found modest reductions among normotensive, mostly older women ([@B13],[@B53]). The effects of lifestyle interventions on lipids appear to be strongest for LDL-C and TC and weaker for any benefit to HDL-C or TG, consistent with similar investigations ([@B14],[@B54]). Previous reports indicated mixed findings regarding the effect of exercise on TG and HDL-C levels; improvements were reported for physically inactive subjects primarily. Indeed, that was the case for the studies in which we found improvements in TG and HDL-C ([@B38],[@B39]). Finally, exercise duration may be the most important predictor of change to HDL-C ([@B55],[@B56]); the 2 studies reporting improvements in TG and HDL-C levels had the longest intervention duration (1-2 y).

The review of guidelines revealed that diagnostic criteria and screening recommendations for dyslipidemia vary. Optimal screening tests include measurement of total and HDL-C levels or apolipoproteins without fasting and without regard to triglycerides ([@B49]). Updated NHLBI guidelines for hypertension and dyslipidemia screening are anticipated in 2012.

We found only 1 study that examined prevalence of hypertension screening and another for dyslipidemia screening among women of reproductive age. One study reported 82% of women of reproductive age received hypertension screening within the preceding year ([@B50]), which is higher than a current estimate of 75% screened (according to unpublished National Health Interview Survey \[NHIS\] data analyses, women aged 14-44 y, 2008). However, nearly 90% of women of reproductive age get hypertension screening within the recommended interval of every 2 years (NHIS data analyses, 2008). Kuklina et al also reported that 49% to 69% of women aged 20 to 45 years had their cholesterol checked in the previous 5 years ([@B51]), which is consistent with estimates from 2008 NHIS unpublished analyses for the same population (64%). The lack of consensus among dyslipidemia screening guidelines may be the reason for lower screening rates in this population.

Few studies provide detailed examination of hypertension and dyslipidemia screening prevalence among women of reproductive age. Perhaps this gap in the literature exists because young people tend to be healthy and the age gradient is marked in these conditions, so women of reproductive age have not been considered a target for screening surveillance. However, identification of high-risk subpopulations and clarification of screening recommendations may prevent the onset of hypertension, dyslipidemia, and other chronic conditions such as diabetes among those at increased risk for CVD.

Substantial body of evidence establishes that diet and exercise improve hypertension and dyslipidemia, but that literature is predominantly based on studies of men and older women. Individual study samples included in this review may lack the power to detect the benefits of lifestyle interventions among healthy populations. For example, pooled results among RCTs that enrolled healthy older women detected significant effects between aerobic exercise and blood pressure, although the individual RCT findings were not significant ([@B53]). Pooling studies in meta-analyses can add the needed statistical power to detect modest short-term benefits of lifestyle interventions, but not enough studies are focused on women of reproductive age to do this.

Women of reproductive age are a population in need of CVD screening and early intervention. Lifestyle modifications are appropriate initial therapies for most patients and may reduce CVD risk through mechanisms other than lowering LDL-C or blood pressure, such as through smoking cessation, weight reduction, and increased physical activity ([@B48]). Moreover, a dose-response effect of physical activity on CHD risk suggests that higher intensity exercise conveys greater benefit ([@B57]-[@B59]).

To our knowledge, this is the first published systematic review of RCTs examining the effects of lifestyle interventions on hypertension, dyslipidemia, or CVD among women of reproductive age. Its strengths include a review of the grey literature, report of study flow, and assessment of the quality of included RCTs. The geographic breadth of included RCTs spanned Africa, Asia, Europe, Oceania, and North and South America. Studies from Europe and North America were most prevalent; thus, results are generally representative of women of reproductive age from those regions. However, racial composition was addressed in only one-third of the studies ([@B20],[@B22],[@B28],[@B29],[@B31],[@B33],[@B34]), and only 5 included minority women ([@B20],[@B22],[@B31],[@B33],[@B35]). Given racial differences in hypertension and dyslipidemia screening ([@B50],[@B60],[@B61]) and the need to explore lifestyle interventions\' benefits in high-risk subpopulations of women of reproductive age, future RCTs should recruit sufficient numbers of at-risk women of reproductive age, including African American and obese women. The main limitation of this review is the possibility of missed studies. We did not search non--English-language literature, and it is possible that RCTs have been published in other languages. We also may have missed potentially relevant studies that are not indexed in PubMed.

Given the reproductive health importance of identifying hypertension or dyslipidemia among women of reproductive age, surveillance of hypertension and dyslipidemia screening in this population is needed. Lifestyle interventions may offer modest short-term benefits for reducing blood pressure or lipids among healthy women of reproductive age that may lead to larger long-term benefits. Further research is needed to clarify predictors of and barriers to cholesterol screening in this population and to investigate the long-term benefits of lifestyle interventions for women of reproductive age.
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###### 

Medical Subject Headings and Free-Text Search Terms Used in Electronic Searches

  -----------------------------------------------------------------------------------------------------------------------------------------------------
  **Terms**                                   Medical Subject Headings                                          Free-Text
  ------------------------------------------- ----------------------------------------------------------------- ---------------------------------------
  **Disease-specific--related terms**         Hypertension\                                                     Blood pressure, high\
                                              \                                                                 \
                                              Hypertension/epidemiology/\*prevention and control\               Hyperlipemia\
                                              \                                                                 \
                                              Dyslipidemia\*\                                                   Hyperlipidemia\
                                              \                                                                 \
                                              Dyslipidemia\*/epidemiology/\*prevention and control\             Lipemia\
                                              \                                                                 \
                                              Hyperlipidemia\*\                                                 Lipidemia\
                                              \                                                                 \
                                              Hyperlipidemia\*/epidemiology/\*prevention and control\           Lipid disorders\
                                              \                                                                 \
                                              Hypercholesterolemia\                                             Cholesterol\
                                              \                                                                 \
                                              Cholesterol, LDL\                                                 Low-density lipoprotein cholesterol\
                                              \                                                                 \
                                              Cholesterol, HDL\                                                 High-density lipoprotein cholesterol\
                                              \                                                                 \
                                              Cardiovascular disease\*\                                         Triglycerides\
                                              \                                                                 \
                                              Cardiovascular disease\*/epidemiology/\*prevention and control\   Adverse events\
                                              \                                                                 \
                                              Complications                                                     Adverse effects

  **Screening and treatment-related terms**   Mass screening\                                                   Screening\
                                              \                                                                 \
                                              Exercise\                                                         Screening trends\
                                              \                                                                 \
                                              Diet\                                                             Exercise\
                                              \                                                                 \
                                              Utilization\                                                      Physical activity\
                                              \                                                                 \
                                              Therapy                                                           Diet\
                                                                                                                \
                                                                                                                Lipid analysis\
                                                                                                                \
                                                                                                                Treatment\
                                                                                                                \
                                                                                                                Disease management\
                                                                                                                \
                                                                                                                Disease prevention

  **Other**                                   Cross-sectional survey\                                           NHANES\
                                              \                                                                 \
                                              Health surveys\                                                   NHIS\
                                              \                                                                 \
                                              Review\                                                           BRFSS\
                                              \                                                                 \
                                              Meta-analysis\                                                    MEPS\
                                              \                                                                 \
                                              Guideline                                                         NAMCS\
                                                                                                                \
                                                                                                                Population survey\
                                                                                                                \
                                                                                                                Systematic review\
                                                                                                                \
                                                                                                                Meta-analysis\
                                                                                                                \
                                                                                                                Clinical practice guideline\
                                                                                                                \
                                                                                                                Evidence-based guidelines\
                                                                                                                \
                                                                                                                Standards
  -----------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: LDL, low-density lipoprotein; HDL, high-density lipoprotein; NHANES, National Health and Nutrition Examination Survey; NHIS, National Health Interview Survey; BRFSS, Behavioral Risk Factor Surveillance System; MEPS, Medical Expenditure Panel Survey; NAMCS, National Ambulatory Medical Care Survey. Asterisk (\*) indicates wildcard in search.

###### 

Selected Characteristics of Randomized Controlled Trials Examining Cardiovascular Effects of Diet

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Study, Setting, and Quality[a](#T2FN1){ref-type="table-fn"}**                                                                                                 Study Population[b](#T2FN2){ref-type="table-fn"}                                                                                          Intervention                                                                                                                                                                             Results
  --------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gerhard et al 2000 ([@B20])\                                                                                                                                    22 healthy white and African American premenopausal women aged 18-45 y living in the Portland area who participated in a previous study   Randomized crossover design assignment to diet order\                                                                                                                                    Low-fat and cholesterol diets were associated withdecreased TCdecreased HDL-Cdecreased LDL-Cincreased TGWhite women (n = 9) had higher VLDL-C cholesterol concentrations and TG than African American women (n = 13). Otherwise, no racial differences were noted.\
  \                                                                                                                                                                                                                                                                                                         \                                                                                                                                                                                        \
  Academic: Oregon Health Sciences University\                                                                                                                                                                                                                                                              Intervention --- Low- to high-fat/cholesterol diet and high- to low-fat/cholesterol diet\                                                                                                Small sample sizes may have impaired ability to detect differences.
  \                                                                                                                                                                                                                                                                                                         \                                                                                                                                                                                        
  Portland, Oregon, United States\                                                                                                                                                                                                                                                                          Protocol --- Follow randomly assigned order of diets. Start first diet x 4 wks; 4-wk washout period; follow other diet for 4 wks                                                         
  \                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  Moderate                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Pellizzer et al 1999 ([@B21])\                                                                                                                                  25 healthy, nonsmoking, premenopausal women aged 18-45 y in 20% of ideal body weight                                                      Randomized, crossover design assignment to 1 of 2 diets\                                                                                                                                 Low-fat diets associated withdecreased DBPdecreased TCdecreased HDL-Cdecreased LDL-Cno significant change in SBPweight did not change significantly
  \                                                                                                                                                                                                                                                                                                         \                                                                                                                                                                                        
  Hospital: Austin Hospital\                                                                                                                                                                                                                                                                                Intervention --- 1st: Low in total and saturated fat (25%) and cholesterol; 2nd: High in total and saturated fat (40%) and cholesterol\                                                  
  \                                                                                                                                                                                                                                                                                                         \                                                                                                                                                                                        
  Victoria, Australia\                                                                                                                                                                                                                                                                                      Protocol --- Follow randomly assigned order of diets. Start first diet, follow for 2 wks; 2-wk washout; Follow other diet for 2 wks                                                      
  \                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  Low                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

  Ginsberg et al 1998 ([@B22])\                                                                                                                                   39 healthy, normolipidemic, premenopausal women recruited from 4 research centers; mean age, 31 y                                         Randomized, crossover design\                                                                                                                                                            Relative to average American diet, Step 1 and Low-SFA diets associated withdecreased TCdecreased HDL-Cdecreased LDL-Cno significant change in TG
  \                                                                                                                                                                                                                                                                                                         \                                                                                                                                                                                        
  Multicenter trials: Columbia University, Pennington Biomedical Research Center, Pennsylvania State University, University of Minnesota, United StatesModerate                                                                                                                                             Intervention --- Diet A: Average American diet with 37% fat, including 16% SFA; diet B: Step 1 diet with 30% fat including 9% SFA; diet C: Low-SFA diet with 26% fat including 5% SFA\   
                                                                                                                                                                                                                                                                                                            \                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                            Protocol --- Randomly assigned a diet sequence that includes each diet: ABC, ACB, BAC, BCA, CAB, or CBA\                                                                                 
                                                                                                                                                                                                                                                                                                            \                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                            Assigned diets were followed for 8 wks, followed by 4- to 6-wk washout between diets, and next diet                                                                                      
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TG, triglycerides; VLDL-C, very low-density lipoprotein cholesterol; DBP, diastolic blood pressure; SBP, systolic blood pressure; SFA, saturated fatty acids.

Quality was defined as ratings based on ECRI Institute 25-item validated instrument ([@B19]).

Number of subjects limited to those who completed the study.

###### 

Selected Characteristics of Randomized Controlled Trials Examining Cardiovascular Effects of Exercise

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Study, Setting, and Quality[a](#T3FN1){ref-type="table-fn"}**   Study Population[b](#T3FN2){ref-type="table-fn"}                                                                                                                  Intervention                                                                                                                                                                                       Results
  ----------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Ciolac et al 2010 ([@B23])\                                       44 healthy female college students\                                                                                                                               Intervention. Five min warm up, 15 min of calisthenics, and either aerobic interval training (AIT, n = 16) or continuous exercise training (CET, n = 16) for 40 min for 3 times/wk for 16 weeks\   Relative to controls, interventions associated withno significant change in TCno significant change in LDL-Cno significant change in HDL-Cno significant change in TGno significant change in SBPno significant change in DBP
  \                                                                 \                                                                                                                                                                 \                                                                                                                                                                                                  
  Brazil\                                                           Mean age by group:\                                                                                                                                               Intensity. AIT = 50%-90% max ventilation oxygen uptake (VO~2MAX~)\                                                                                                                                 
  \                                                                 \                                                                                                                                                                 \                                                                                                                                                                                                  
  Moderate\                                                         Aerobic interval training = 24.4 y; continuous exercise training = 26.6 y; control = 25.3 y\                                                                      CET = 60%-70% VO~2MAX~                                                                                                                                                                             
  \                                                                 \                                                                                                                                                                                                                                                                                                                                                                    
                                                                    Intervention, n = 16; control, n = 12                                                                                                                                                                                                                                                                                                                                

  Boreham et al 2005 ([@B24])\                                      15 sedentary, but otherwise healthy, young female college students\                                                                                               Intervention. Stair-climbing program 5 times/wk for 8 wks\                                                                                                                                         Relative to controls, interventions associated with:decreased LDL-Cno significant change in TCno significant change in HDL-Cno significant change in TG
  \                                                                 \                                                                                                                                                                 \                                                                                                                                                                                                  
  Northern Ireland, UK\                                             Mean age, 18.8 y\                                                                                                                                                 Intensity. Progressive starting with 2 sets (199 stairs) at 90 steps/min and working up to 5 sets                                                                                                  
  \                                                                 \                                                                                                                                                                                                                                                                                                                                                                    
  High                                                              Intervention, n = 8; control, n = 7                                                                                                                                                                                                                                                                                                                                  

  Kin Isler et al 2001 ([@B25])\                                    45 sedentary female college student volunteers\                                                                                                                   Intervention. Step aerobics (n = 15) or aerobic dancing (n = 15) for  45 min, 3 times/wk for 8 wksIntensity. Sixty to 70% heart rate reserve                                                       Relative to controls, both interventions associated withdecreased TCno significant change in TGno significant change in LDL-CRelative to controls, step aerobics associated with increased HDL-C
  \                                                                 \                                                                                                                                                                                                                                                                                                                                                                    
  Ankara, Turkey\                                                   Mean age by group: Step aerobics = 21.9 y; aerobic dancing = 20.2 y; control = 21.9 y\                                                                                                                                                                                                                                                                               
  \                                                                 \                                                                                                                                                                                                                                                                                                                                                                    
  Moderate                                                          Intervention, n = 30; control, n = 15                                                                                                                                                                                                                                                                                                                                

  LeMura et al 2000 ([@B26])\                                       45 college-aged, nonsmoking female students with no regular physical activity for 4 mo before study, and taking no medications known to alter lipid metabolism\   Intervention. Resistance training (n = 11), aerobic training (n = 10), or cross training (n = 12) for 3 times/wk for 16 wks\                                                                       Relative to controls, interventions associated withno significant change in TCno significant change in LDL-Cno significant change in HDL-Cno significant change in TG
  \                                                                 \                                                                                                                                                                 \                                                                                                                                                                                                  
  Pennsylvania, United States\                                      Mean age = 20.4 y\                                                                                                                                                Intensity. Resistance = Nautilus 3 times per wk; aerobic = 3 times per wk; cross-training = aerobics 2 times/wk and Nautilus 2 times/wk\                                                           
  \                                                                 \                                                                                                                                                                 \                                                                                                                                                                                                  
  Moderate                                                          Intervention, n = 33; control, n = 12                                                                                                                             Control. No training during 16 wks.                                                                                                                                                                

  Prabhakaran et al 1999 ([@B27])\                                  24 sedentary, premenopausal healthy women recruited by campus newspaper and word of mouth\                                                                        Intervention. Supervised, intensive, resistance exercise training sessions 45-50 min/d, 3 d/wk for 14 wks\                                                                                         Relative to controls, intervention associated withdecreased TCno significant change in LDL-Cno significant change in HDL-Cno significant change in TGno significant change in body mass
  \                                                                 \                                                                                                                                                                 \                                                                                                                                                                                                  
  Virginia, United States\                                          Mean age by group: resistance training, 28.0 y; control, 26.0 y\                                                                                                  Control. Nonexercising                                                                                                                                                                             
  \                                                                 \                                                                                                                                                                                                                                                                                                                                                                    
  Moderate                                                          Intervention, n = 12; control, n = 12                                                                                                                                                                                                                                                                                                                                

  Duey et al 1998 ([@B33])\                                         25 sedentary African American women\                                                                                                                              Intervention. Endurance exercise training sessions  20 min/d (plus warm-up and cool-down), 3 d/week for 6 wks\                                                                                     Relative to controls, intervention associated withno significant change in SBPno significant change in DBP
  \                                                                 \                                                                                                                                                                 \                                                                                                                                                                                                  
  Alabama, United States\                                           Mean age by group: intervention, 23.6 y; control, 22.2 y\                                                                                                         Intensity. Weeks 1-2: 60% peak oxygen uptake (VO~2peak~); weeks 3-4: 65% VO~2peak~; weeks 5-6: 70% VO~2peak~\                                                                                      
  \                                                                 \                                                                                                                                                                 \                                                                                                                                                                                                  
  Moderate                                                          Intervention, n = 16; control, n = 9                                                                                                                              Control. Usual diet and physical activity                                                                                                                                                          

  Santiago et al 1995 ([@B28])\                                     27 mostly white, healthy female volunteers aged 22-40 y, nonsmokers, not pregnant, sedentary, body mass index \<31 kg/m^2^\                                       Intervention. Brisk treadmill walking for 3 miles,  4 d/wk for 40 wks\                                                                                                                             Relative to controls, intervention associated withno significant change in HDL-Cno significant change in LDL-Cno significant change in TCno significant change in TGno significant change in body composition
  \                                                                 \                                                                                                                                                                 \                                                                                                                                                                                                  
  Minnesota, United States\                                         Intervention, n = 16; control, n = 11                                                                                                                             Intensity. 72% maximal heart rate\                                                                                                                                                                 
  \                                                                                                                                                                                                                                   \                                                                                                                                                                                                  
  Moderate                                                                                                                                                                                                                            Control. Sedentary                                                                                                                                                                                 

  Boyden et al 1993 ([@B29])\                                       88 white, healthy female volunteers aged 28-39 y, smoked ≤10 cigarettes/d, inactive, not overweight or obese\                                                     Intervention. Resistance exercising for 1 hour, 3 d/wk for 5 mos\                                                                                                                                  Relative to controls, intervention associated withdecreased LDL-Cdecreased TCno significant change in HDL-Cno significant change in TG
  \                                                                 \                                                                                                                                                                 \                                                                                                                                                                                                  
  Arizona, United States\                                           Intervention, n = 46; control, n= 42                                                                                                                              Intensity. Load major muscle groups in the arms, legs, trunk, and lower back\                                                                                                                      
  \                                                                                                                                                                                                                                   \                                                                                                                                                                                                  
  Moderate                                                                                                                                                                                                                            Control. Inactive                                                                                                                                                                                  

  Hinkleman et al 1993 ([@B30])\                                    36 premenopausal female volunteers aged 25-45 y, not presently exercising or dieting, 10%-40% overweight, nonsmokers, no history of alcohol or drug abuse\        Intervention. Walking 45 min, 5 d/wk for 15 wks\                                                                                                                                                   Relative to controls, intervention associated withno significant change in LDL-Cno significant change in TCno significant change in TGdecreased HDL-Csignificant change in body weightno significant change in body fat
  \                                                                 \                                                                                                                                                                 \                                                                                                                                                                                                  
  California, United States\                                        Intervention, n = 18; control, n = 18                                                                                                                             Intensity.  Sixty percent heart rate\                                                                                                                                                              
  \                                                                                                                                                                                                                                   \                                                                                                                                                                                                  
  Moderate                                                                                                                                                                                                                            Control. Non-exercising                                                                                                                                                                            

  Katz et al 1992 ([@B34])\                                         21 white, healthy female volunteers aged 18-28 y, nonsmokers, inactive, no history of cardiovascular disease\                                                     Intervention.  Low-intensity resistance exercise training on Nautilus 30 min/d, 3 d/wk for 6 wks\                                                                                                  Relative to controls, intervention associated withno significant change in SBPno significant change in DBP
  \                                                                 \                                                                                                                                                                 \                                                                                                                                                                                                  
  Ohio, United States\                                              Intervention, n = 13; control, n= 8                                                                                                                               Control. Not trained                                                                                                                                                                               
  \                                                                                                                                                                                                                                                                                                                                                                                                                                      
  Moderate                                                                                                                                                                                                                                                                                                                                                                                                                               

  Duncan et al 1991 ([@B31])\                                       53 mixed-race, healthy women aged 20-40 y, nonsmokers, sedentary, \"light or nondrinkers\"\                                                                       Intervention. Aerobic walking (n = 13), brisk walking (n = 12), or strolling (n = 18)  4.8 km, 5 d/wk for 24 wks\                                                                                  Relative to controls, intervention associated withno significant change in seated blood pressureno significant change in TCno significant change in LDL-Cno significant change in HDL-Cno significant change in TG
  \                                                                 \                                                                                                                                                                 \                                                                                                                                                                                                  
  Texas, United States\                                             Intervention, n = 43; control, n = 10                                                                                                                             Intensity. Aerobic walkers, 8.0 km/h; brisk walkers, 6.4 km/h; strollers, 4.8 km/h\                                                                                                                
  \                                                                                                                                                                                                                                   \                                                                                                                                                                                                  
  Moderate                                                                                                                                                                                                                            Control. Sedentary                                                                                                                                                                                 

  Edin et al 1990 ([@B32])\                                         17 healthy, nonpregnant women aged 18-40 y, sedentary, nonsmokers with body weight within 80%-120% of standard body weight for height range\                      Intervention. Aerobic exercise on trampoline 30 min, 5 d/wk for 11 wks\                                                                                                                            Relative to controls, intervention associated withno significant change in TCno significant change in HDL-Cno significant change in TG
  \                                                                 \                                                                                                                                                                 \                                                                                                                                                                                                  
  Minnesota, United States\                                         Intervention, n = 10; control, n = 7                                                                                                                              Intensity. Training heart rate zone of 70%-85% of maximal heart rate\                                                                                                                              
  \                                                                                                                                                                                                                                   \                                                                                                                                                                                                  
  Moderate                                                                                                                                                                                                                            Control. Sedentary                                                                                                                                                                                 

  Oluseye et al 1990 ([@B35])\                                      42 sedentary Nigerian women, aged 20-50 yIntervention, n = 30; control, n = 12                                                                                    Intervention. Interval Aerobic Training Protocol (ITP) (n = 15) or Continuous Aerobic Training Protocol (CTP) (n = 15) 50 min, 3 d/wk for 12 wks\                                                  Relative to controls, interventions associated withdecreased SBPdecreased DBP
  \                                                                                                                                                                                                                                   \                                                                                                                                                                                                  
  Ibadan, Nigeria\                                                                                                                                                                                                                    Intensity. Progressive 65%-95% of maximal heart rate with increases of 5% every 2 wks\                                                                                                             
  \                                                                                                                                                                                                                                   \                                                                                                                                                                                                  
  Moderate                                                                                                                                                                                                                            Control. Sedentary                                                                                                                                                                                 
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; TG, triglycerides; SBP, systolic blood pressure; DBP, diastolic blood pressure.

Quality ratings based on ECRI Institute 25-item validated instrument ([@B20]).

Number of subjects limited to those who completed the study.

###### 

Selected Characteristics of Randomized Controlled Trials Examining Cardiovascular Effects of Diet and Exercise

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Study, Setting, and Quality[a](#T4FN1){ref-type="table-fn"}**   Study Population[b](#T4FN2){ref-type="table-fn"}                                                                                                                                                                                                                                                                                                                         Intervention                                                                                                                                                                                                                                                                                                                                                       Results
  ----------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Esposito et al 2003 ([@B39])\                                     120 premenopausal, sedentary, obese, nonpregnant women aged 20-46 y recruited from the outpatient department for weight loss of the teaching hospital. Exclusion criteria: dieting within previous 6 mos, type 2 diabetes or impaired glucose tolerance, hypertension, cardiovascular disease, psychological problems, alcohol abuse, smokers, and any medication use\   Intervention. Individual counseling on increasing physical activity for 2 y; small group sessions on reducing dietary calories, personal goal setting, and self-monitoring\                                                                                                                                                                                        Relative to controls, intervention associated withdecreased SBPdecreased DBPdecreased TGincreased HDL-Cno significant change in TCBlood pressure and cholesterol were secondary outcomes of the study; primary outcomes were inflammatory markers.\
  \                                                                 \                                                                                                                                                                                                                                                                                                                                                                        \                                                                                                                                                                                                                                                                                                                                                                  \
  Naples, Italy\                                                    Intervention, n = 60; control, n = 60                                                                                                                                                                                                                                                                                                                                    Intensity. Monthly sessions with a nutritionist and exercise trainer for 12 mos, bimonthly for 12 mos\                                                                                                                                                                                                                                                             No adjustments were made for multiple comparisons.
  \                                                                                                                                                                                                                                                                                                                                                                                                                                          \                                                                                                                                                                                                                                                                                                                                                                  
  High                                                                                                                                                                                                                                                                                                                                                                                                                                       Control. Monthly group education sessions                                                                                                                                                                                                                                                                                                                          

  Janssen et al 2002 ([@B36])\                                      38 premenopausal, upper-body obese, women with stable weight in 6 mos before study, taking no medications, with regular menses\                                                                                                                                                                                                                                          Intervention. Weight maintenance diet for 2 wks before pretreatment testing\                                                                                                                                                                                                                                                                                       Relative to controls, intervention associated withno significant change in TCno significant change in LDL-Cno significant change in HDL-Cno significant change in TG
  \                                                                 \                                                                                                                                                                                                                                                                                                                                                                        \                                                                                                                                                                                                                                                                                                                                                                  
  Ontario, Canada\                                                  Mean age by group: diet and aerobics = 37.5 y; diet and resistance = 34.8 y; diet only = 40.1 y\                                                                                                                                                                                                                                                                         Diet and aerobics (DA) (n = 11); diet and resistance (DR) (n = 14); weight reduction diet for 16 wks\                                                                                                                                                                                                                                                              
  \                                                                 \                                                                                                                                                                                                                                                                                                                                                                        \                                                                                                                                                                                                                                                                                                                                                                  
  Moderate                                                          Intervention, n = 25; control, n = 13                                                                                                                                                                                                                                                                                                                                    Intensity. Diet = 1000 kcal deficit diet; DA = 15-60 min sessions of aerobic exercise for 5 d/wk; DR = 5-10 min cycling and 30 min sessions of resistance exercise 3 d/wk\                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                             \                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                             Control. Diet only                                                                                                                                                                                                                                                                                                                                                 

  Fogelholm et al 2000 ([@B40])\                                    74 premenopausal, healthy, sedentary female volunteers aged 30-45 y with body mass index 30-45 kg/m^2^ and stable weight over previous 3 months, nonbingeing, not taking medication other than birth control, and not pregnant, lactating, or smoker\                                                                                                                    Intervention. Twelve wks weight reduction diet followed by maintenance program for 40 wks with weekly small group meetings and random assignment to walk-1 (n = 24), walk-2 (n = 23), or control (n = 27); unsupervised 2-year follow-up\                                                                                                                          Relative to controls, interventions associated withno significant change in TCno significant change in HDL-Cno significant change in TGno significant change in SBPno significant change in DBPBlood pressure and cholesterol were secondary outcomes of the study; primary outcomes were body weight, fat mass, and waist circumference.
  \                                                                 \                                                                                                                                                                                                                                                                                                                                                                        \                                                                                                                                                                                                                                                                                                                                                                  
  UKK Institute, Tampere, Finland\                                  Intervention, n = 47; control, n = 27                                                                                                                                                                                                                                                                                                                                    Intensity. Walk-1 average 2-3 h weekly; walk-2 group average 4-6 h weekly\                                                                                                                                                                                                                                                                                         
  \                                                                                                                                                                                                                                                                                                                                                                                                                                          \                                                                                                                                                                                                                                                                                                                                                                  
  Moderate                                                                                                                                                                                                                                                                                                                                                                                                                                   Control. Diet counseling with no change in exercise during maintenance program                                                                                                                                                                                                                                                                                     

  Ågren et al 1991 ([@B37])\                                        99 healthy female students (age not specified)\                                                                                                                                                                                                                                                                                                                          Intervention. Fish diet (n = 22), exercise (n = 27), or fish diet and exercise (n = 27) for 14 wks\                                                                                                                                                                                                                                                                Relative to controls, fish diet and exercise interventions associated withdecreased TGno significant change in TCno significant change in LDL-Cno significant change in HDL-C
  \                                                                 \                                                                                                                                                                                                                                                                                                                                                                        \                                                                                                                                                                                                                                                                                                                                                                  
  University setting in Finland\                                    Intervention, n = 76; control, n = 23                                                                                                                                                                                                                                                                                                                                    Intensity. Fish diet: offered meal containing 150g fish for 5 d/wk but uptake was 3.5 d/wk; aerobic exercise: advised to obtain 30 min moderate intensity aerobic activity ≥3 times/wk but uptake was 1.3 times/wk\                                                                                                                                                
  \                                                                                                                                                                                                                                                                                                                                                                                                                                          \                                                                                                                                                                                                                                                                                                                                                                  
  Low                                                                                                                                                                                                                                                                                                                                                                                                                                        Fish diet and aerobic exercise: as described above                                                                                                                                                                                                                                                                                                                 

  Wood et al 1991 ([@B38])\                                         112 healthy, sedentary, moderately overweight, nonsmoking, female volunteers aged 25-49 y, consuming \<4 alcoholic drinks/d, not taking medication that could affect blood pressure or cholesterol, not lactating, pregnant, or taking oral contraceptives in past 6 mos, and not planning pregnancy in next 2 years\                                                    Intervention. Diet-only (n = 31) or diet and exercise (n = 42)\                                                                                                                                                                                                                                                                                                    Relative to controls interventions associated withdecreased TCdecreased LDL-Cdecreased TGdecreased SBPdecreased DBPno significant change in HDL-CRelative to diet only group, diet and exercise associated with increased HDL-C
  \                                                                 \                                                                                                                                                                                                                                                                                                                                                                        \                                                                                                                                                                                                                                                                                                                                                                  
  Stanford University, Palo Alto, California, USA\                  Intervention, n = 73; control, n = 39                                                                                                                                                                                                                                                                                                                                    Intensity. Daily diet consisting of 55% carbohydrates and 30% fat with ≤10% saturated fat and ≤300 mg cholesterol; weekly group sessions for 3 mos followed by every other week for 3 mos and monthly for 6 mos; supervised progressive aerobic exercise: brisk walking and jogging 3 d/wk at 25 min per session increasing to 45 min per sessions by 4th month\   
  \                                                                                                                                                                                                                                                                                                                                                                                                                                          \                                                                                                                                                                                                                                                                                                                                                                  
  Moderate                                                                                                                                                                                                                                                                                                                                                                                                                                   Control. Asked to maintain usual diet and exercise habits                                                                                                                                                                                                                                                                                                          
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: SBP, systolic blood pressure; DBP, diastolic blood pressure; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol.

Quality ratings based on ECRI Institute 25-item validated instrument ([@B20]).

Number of subjects limited to those who completed the study.

###### 

National Blood Pressure and Cholesterol Screening Guidelines for Diagnosing Hypertension and Dyslipidemia in Women

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Developer and Year**                                                         Who and When to Screen                                                                                                                                                                                                                            Risk Factors                                                                                                                                                                                                                                                                                                                                                                                                                           Diagnostic Criteria
  ------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Hypertension**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  American Academy of Family Physicians (AAFP) ([@B42]) 2011                     WHO: Women aged ≥18 y\                                                                                                                                                                                                                            References USPSTF\                                                                                                                                                                                                                                                                                                                                                                                                                     References USPSTF\
                                                                                 \                                                                                                                                                                                                                                                 \                                                                                                                                                                                                                                                                                                                                                                                                                                      \
                                                                                 References US Preventive Services Task Force (USPSTF)\                                                                                                                                                                                            Smoking, diabetes, abnormal blood lipid values, older age, sex, sedentary lifestyle, and obesity                                                                                                                                                                                                                                                                                                                                       SBP ≥140 mm Hg and/or  DBP ≥90 mm Hg\
                                                                                 \                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        \
                                                                                 WHEN: Healthy and at-risk adults: not stated but refers to JNC7                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          ≥2 elevated readings obtained on ≥2 visits over a period of 1 to several weeks

  American College of Obstetricians and Gynecologists (ACOG) ([@B62]) 2007       WHO: Women aged ≥18 y\                                                                                                                                                                                                                            African American, older age, prehypertension, family history of hypertension, lifestyle factors associated with hypertension                                                                                                                                                                                                                                                                                                           See criteria used by the National Heart, Lung, and Blood Institute (NHLBI) Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC7)
                                                                                 \                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                 WHEN: Healthy and at-risk adults: not stated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  American Heart Association (AHA) ([@B43]) 2011                                 WHO: Women aged ≥20 y\                                                                                                                                                                                                                            High risk: CHD, cerebrovascular disease, PAD, abdominal aortic aneurysm, end-stage or chronic renal disease, diabetes mellitus, 10-y Framingham global risk \>20%\                                                                                                                                                                                                                                                                     SBP ≥140 mm Hg or DBP ≥90 mm Hg, or SBP ≥130 mm Hg or DBP ≥80 mm Hg if chronic kidney disease or diabetes is present
                                                                                 \                                                                                                                                                                                                                                                 \                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                                                 WHEN: Healthy and at-risk adults: not stated, but refers to JNC7                                                                                                                                                                                  At risk: cigarette smoking, prehypertension, dyslipidemia, obesity, poor diet, physical inactivity, obesity, family history of premature CVD, metabolic syndrome, hypertension, dyslipidemia, evidence of vascular disease, subclinical atherosclerosis, metabolic syndrome, poor exercise capacity, systemic autoimmune collagen-vascular disease, history of preeclampsia, gestational diabetes, or pregnancy-induced hypertension   

  Institute for Clinical Systems Improvement (ICSI) ([@B44],[@B45]) 2008, 2009   WHO: Average-risk, asymptomatic women aged ≥18 y\                                                                                                                                                                                                 Hypertension, age, diabetes mellitus, elevated LDL-C, low HDL-C, estimated GFR \<60 mL/min, microalbuminuria, family history of premature CVD, obesity, physical inactivity, tobacco use, target organ damage to heart, brain, chronic kidney disease, PAD, or retinopathy                                                                                                                                                             Prehypertension:\
                                                                                 \                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        \
                                                                                 WHEN: Healthy adults: every 2 years\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     SBP = 120-139 mm Hg or DBP = 80-89 mm Hg\
                                                                                 \                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        \
                                                                                 At-risk adults: prehypertension, 1 y; stage 1 hypertension, 2 mos; stage 2 hypertension, within 1 mo                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Stage 1 hypertension:\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          SBP ≥140-159 mm Hg or, DBP ≥90-99 mm Hg\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Stage 2 hypertension:\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          SBP ≥160 mm Hg or, DBP ≥100 mm Hg\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Initial visit plus 2 follow-up visits, each including 2 measures per visit

  NHLBI JNC7 ([@B41]) 2003                                                       WHO: Adult women\                                                                                                                                                                                                                                 Hypertension, older age, diabetes mellitus, elevated LDL-C or total cholesterol or low HDL-C, estimated GFR \<60 mL/min, family history of premature CVD, microalbuminuria, obesity, physical inactivity, tobacco usage, target organ damage to heart, brain, chronic kidney disease, PAD, or retinopathy                                                                                                                              Prehypertension:SBP = 120-139 mm Hg or DBP = 80-89 mm Hg\
                                                                                 \                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        \
                                                                                 WHEN: Healthy adults: every 2 y\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Stage 1 hypertension, SBP ≥140 mm Hg or DBP ≥90 mm Hg\
                                                                                 \                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        \
                                                                                 At-risk adults: prehypertension, 1 y; stage 1 hypertension, 2 mos; stage 2 hypertension, within 1 mo, or if SBP ≥180 mm Hg or DBP ≥110 mm Hg, treat immediately or within 1 wk depending on clinical situation and complications                                                                                                                                                                                                                                                                                                                                                                                                                                                         Stage 2 hypertension, SBP ≥160 mm Hg or DBP ≥100 mm Hg\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Average of ≥2 seated blood pressure measurements per visit on ≥2 office visits

  US Preventive Services Task Force (USPSTF) ([@B46]) 2007                       WHO: Women aged ≥18 y without known hypertension\                                                                                                                                                                                                 Smoking, diabetes, abnormal blood lipid values, age, sex, sedentary lifestyle, and obesity                                                                                                                                                                                                                                                                                                                                             Initial visit ≥2 follow-up visits within a few weeks to 1 mo, each including 2 measures per visit
                                                                                 \                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                 WHEN: Healthy and at-risk adults: not stated but refers to JNC7                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Veterans Health Administration (VHA) ([@B47]) 2004, revised 2005               WHO: Women aged ≥17 y\                                                                                                                                                                                                                            Tobacco use, dyslipidemia, diabetes mellitus, obesity, physical inactivity, microalbuminuria or estimated GFR \<60 mL/min, age (\>65 y for women), family history of CVD for women younger than 65 or men younger than 55                                                                                                                                                                                                              Stage 1 hypertension, SBP ≥140 mm Hg or DBP ≥90 mm Hg\
                                                                                 \                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        \
                                                                                 WHEN: Healthy adults: annually\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Stage 2 hypertension, SBP ≥160 mm Hg or DBP ≥100 mm Hg\
                                                                                 \                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        \
                                                                                 At-risk adults: stage 1 hypertension, 2 mos; stage 2 hypertension, within 1 mo                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           2 separate visits within 1-2 mo or sooner, each including ≥2 measures per visit

  **Dyslipidemia**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  AAFP ([@B42]) 2011                                                             WHO: At-risk women aged 20-45 yReferences USPSTF.\                                                                                                                                                                                                See USPSTF                                                                                                                                                                                                                                                                                                                                                                                                                             See USPSTF
                                                                                 \                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                 WHEN: Healthy adults: No recommendation\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
                                                                                 \                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                 At-risk adults: Uncertain; reasonable option is at least once every 5 years, shorter intervals for people who have lipid levels close to those warranting therapy, longer intervals for those with repeatedly normal lipid levels                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  ACOG ([@B62]) 2007                                                             WHO: Women aged ≥45 y and younger women with risk factorsWHEN: Healthy and at-risk adults: not stated but refers to Adult Treatment Panel III (ATP III)                                                                                           Presence of CHD, diabetes, other clinical forms of atherosclerotic disease, cigarette smoking, hypertension, low HDL-C, family history of premature CHD, and older age                                                                                                                                                                                                                                                                 Recommends fasting and no exercise, tobacco use, or caffeine before measurementRefers to ATP III

  AHA ([@B43]) 2011                                                              WHO: Women aged ≥20 y\                                                                                                                                                                                                                            High risk: CHD, CVD, PAD, abdominal aortic aneurysm, end-stage or chronic renal disease, diabetes mellitus, 10-y Framingham global risk of ≥10%\                                                                                                                                                                                                                                                                                       LDL-C ≥100 mg/dL\
                                                                                 \                                                                                                                                                                                                                                                 \                                                                                                                                                                                                                                                                                                                                                                                                                                      \
                                                                                 WHEN: Healthy and at-risk adults: no recommendation                                                                                                                                                                                               At risk: cigarette smoking, prehypertension, dyslipidemia, obesity, poor diet, physical inactivity, family history of premature CVD, metabolic syndrome, evidence of subclinical atherosclerosis, poor exercise capacity, systemic autoimmune collagen-vascular disease, history of preeclampsia, gestational diabetes, or pregnancy-induced hypertension                                                                              HDL-C ≤50 mg/dL\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          TG ≥150 mg/dL\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Non-HDL-C ≥130 mg/dL

  ICSI ([@B45],[@B63]) 2009                                                      WHO: Women aged ≥45 y and at-risk women aged 20-44 y\                                                                                                                                                                                             First-degree relatives with total cholesterol \>300 mg/dL or history of premature CHD; personal history of CHD, CVD, peripheral vascular disease, diabetes mellitus, metabolic syndrome, current dyslipidemia\                                                                                                                                                                                                                         TC ≥200 mg/dL\
                                                                                 \                                                                                                                                                                                                                                                 \                                                                                                                                                                                                                                                                                                                                                                                                                                      \
                                                                                 WHEN: Healthy adults: every 5 yAt-risk adults: every 3-12 mos                                                                                                                                                                                     Also refers to ATP III definitions of high risk                                                                                                                                                                                                                                                                                                                                                                                        LDL-C ≥130 mg/dL\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          TG ≥200 mg/dL\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          HDL-C \<40 mg/dL

  NHLBI, National Cholesterol Education Program, ATP III ([@B48]) 2002           WHO: Women aged ≥20 y\                                                                                                                                                                                                                            High risk: CHD, or CHD risk equivalent including PAD, carotid artery disease, abdominal aortic aneurysm, type 2 diabetes, 10-y Framingham global risk of \>20% due to multiple risk factors including cigarette smoking, hypertension, low HDL-C, family history of premature CHD, aged ≥55 y for women                                                                                                                                Optimal/Desirable: TC \<200 mg/dL, LDL-C \<100 mg/dL, HDL-C ≥60 mg/dL, TG \<150 mg/dL\
                                                                                 \                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        \
                                                                                 WHEN: Healthy adults: at least once every 5 y\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Above optimal: LDL-C = 100-129 mg/dL\
                                                                                 \                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        \
                                                                                 At-risk adults: more frequent measurements are required for persons with multiple risk factors or, in those with 0-1 risk factor, if the LDL-C level is only slightly below the goal level                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Borderline high: TC = 200-239 mg/dL, LDL-C = 130-159 mg/dL, TG = 150-199 mg/dL\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          High: TC ≥240 mg/dL, LDL-C = 160-189 mg/dL, HDL-C \<40 mg/dL, TG = 200-499 mg/dL\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Very high: LDL-C ≥190 mg/dL, TG ≥500 mg/dL

  USPSTF ([@B64]) 2008                                                           WHO: At-risk women aged 20-45 y\                                                                                                                                                                                                                  Diabetes, previous personal history of CHD or noncoronary atherosclerosis, family history of CVD before age 50 in male relatives or age 60 in female relatives, tobacco use, hypertension, obesity                                                                                                                                                                                                                                     TC and HDL-C (fasting or nonfasting)\
                                                                                 \                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        \
                                                                                 WHEN: Healthy adults: no recommendation\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Confirm abnormal screening test results with a repeated sample on a separate occasion, and the average of both results should be used for risk assessment
                                                                                 \                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                 At-risk adults: uncertain; reasonable options include every 5 y, shorter intervals for people who have lipid levels close to those warranting therapy, and longer intervals for those not at increased risk with repeatedly normal lipid levels                                                                                                                                                                                                                                                                                                                                                                                                                                          

  VHA ([@B65]) 2006                                                              WHO: All adult women aged ≥45 y and adult women \<45 y with ≥1 risk factors\                                                                                                                                                                      Older age, family history of premature CVD, hypertension, or under treatment for hypertension, smoking, diabetes mellitus, abdominal obesity                                                                                                                                                                                                                                                                                           Fasting lipid profile including TC ≥240 mg/dL, HDL-C \<40 mg/dL, TG \>200 mg/dL, LDL-C ≥130 mg/dL, if calculated but consider direct measurement of LDL-C if TG \>400 mg/dL
                                                                                 \                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                 WHEN: Healthy adults: every 5 years\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                                                 \                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                 At-risk adults: more often if family history of premature CVD exists                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: NHLBI, National Heart, Lung, and Blood Institute; JNC 7, the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; AAFP, American Academy of Family Physicians; SBP, systolic blood pressure; DBP, diastolic blood pressure; CHD, coronary heart disease; PAD, peripheral artery disease; CVD, cardiovascular disease; PAD, peripherial artery disease; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; GFR, glomerular filtration rate; TG, triglycerides; TC, total cholesterol.
